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Chronic painAbstract Aim of the work: Illness perception is considered to be an important contributor in the
relationship between physical and psychological factors in rheumatoid arthritis (RA). This study
examined the mediational role of illness perceptions in the relationship between depression and pain
in RA.
Patients and methods: Illness perception, depression and pain were assessed in 100 adults with
RA (72 females and 28 males). Patients were asked to complete 4 questionnaires including socio-
demographic data form, depression subscale of Hospital Anxiety and Depression Scale (HADS),
Brief Illness Perception Questionnaire (Brief-IPQ) and Rheumatoid Arthritis Pain Scale (RAPS).
Using the Baron and Kenny approach and Sobel tests, the mediation of illness perceptions in the
relationship between depression and pain symptoms was examined.
Results: Sixty-six RA patients (66%) endorsed a clinically signiﬁcant level of depression (HADS
12.94 ± 5.39). The mean RAPS was 41.97 ± 23.45 (range = 4–91.93). Depression symptoms were
signiﬁcantly associated with perceived pain (r= 0.57, p< 0.001). Three illness perceptions signif-
icantly mediated the relationship between depression and pain; consequences (z= 1.39, p< 0.05);
58 F. Rezaei et al.personal control (z= 1.47, p< 0.05) and emotional response (z= 1.51, p< 0.05). Gender and
education showed no signiﬁcant effect on the presented results.
Conclusions: Greater depression symptoms were associated with perceptions that pain negatively
affected one’s life and emotions and was difﬁcult to control. These negative illness perceptions were,
in turn, related to greater pain symptoms. Illness perceptions helped explain the depression-pain
link in RA patients. Results suggest that targeting illness perceptions in adults with RA and depres-
sion may help reduce pain symptoms.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society for Joint Diseases and
Arthritis.Open access under CC BY-NC-ND license.1. Introduction
Rheumatoid arthritis (RA) is a systemic auto-immune disease
that affects between 0.5% and 1% of the adult population
worldwide [1]. The diagnosis of RAmay cause stress and uncer-
tainty in patients [2]. The bio-psycho-social model of illness
highlights the importance of biological, psychological and envi-
ronmental contributors to the etiology and treatment of all dis-
eases [3]. Although there is a large amount of evidence pointing
to the biological factors related to chronic pain such as RA,
there is a growing body of evidence of psychological and social
factors affecting the course and outcome of pain [4–6].
RAcanaffect all aspects of one’s life, like social relationships,
family life, and psychological well-being in addition to physical
symptoms [7–9]. It has been shown that RA patients are either
quit or change their jobs in a 2-year period with a rate of 33 and
16%, respectively [8]. In addition to these stressors, pain, restric-
tion of activities and physical handicaps are associated with
changes in psychological aspect. RA is related with signiﬁcant
psychiatric morbidity. The main psychiatric disorders reported
in RA cases are anxiety, depression, or both [9–13].
While the mechanism underlying the relationship between
pain and depression remains unknown, the presence of depres-
sion disorder has been repeatedly linked to poor health, in-
creased higher levels of pain, impaired mood and functional
disability in RA patients [14–16].
It is important to understand how pain and depression are
related in RA patients. Understanding mediating factors of the
depression-pain relationship in RA patients may help to im-
prove pain symptoms and ultimately health related quality of
life. Although examination of potential mediators is essential
to fully understand this association, this study focuses on the
role of cognitions.
Cognitive appraisal and illness perceptions are considered
to be important contributing factors in relationship between
physical and psychological factors in chronic pain. Based on
the cognitive-behavioral mediation proposed by kerns and
Turk [17], cognitive appraisal factors are one possible pathway
through which depression symptoms may be related to pain
symptoms. Lefebvre and Keefe [18] showed that catastrophic
cognitions were related to the recall of both pain intensity
and pain variability in RA patients.
The illness perceptions are the organized cognitive repre-
sentations that patients have about their diseases and inﬂu-
ences the way patients cope with their complaints [19,20].
The self-regulation model suggests that the cognitive and emo-
tional aspects of illness perception guide the response to illness
and determine the effectiveness of coping strategies [21]. Fur-
thermore, components of illness perception have been recog-nized: the identity of the illness (i.e. the symptoms), the
perceived consequences of the illness, the illness’s causation;
the illness’s likely time line and the potential for control or cure
[22]. Thus, further examination of depression, illness percep-
tion and pain symptoms could inform psychological treatment
methods for depression in RA patients. Therefore, the purpose
of this study was to examine the possible mediation role of ill-
ness perceptions in the depression-pain symptoms relationship
in RA patients. It was hypothesized that RA patients with in-
creased symptoms of depression would perceive their illness to
be more negative, and as a result, experience greater pain
symptoms.
2. Patients and methods
2.1. Patients
A cross-sectional study was used to examine the depression
and determinants of illness perception (8 components) to iden-
tify predictors of pain in RA patients. This study was approved
by the research ethics board of Isfahan University of Medical
Sciences.
The study included 100 RA patients diagnosed according to
the revised American College of Rheumatology (ACR) criteria
for classiﬁcation of RA [23]. These patients were recruited
from an outpatient rheumatology clinic afﬁliated with Isfahan
University of Medical Sciences during December 2011 – Au-
gust 2012. Of the initial sample of 115 patients, 15 (13.04%)
were excluded because of incomplete data. The ﬁnal sample
consisted of 100 patients, including 72 females with a mean
age of 45.46 ± 12.67 years and 28 males with a mean age of
40.68 ± 13.99 years. The mean length of total education was
13.07 ± 2.72 years (range 9–18 years).
Disease duration ranged between 6 months and 26 years
with a mean of 5.67 ± 5.74 years. It was computed from the
disease onset to the time of the questionnaires administering.
Men and women did not differ in age, duration of disease
and education. Inclusion criteria were: (1) receiving the diag-
nosis of RA by a rheumatologist (the last author), (2) age
18–70 years old, (3) being able to write and read and (4) will-
ingness to participate in the study. Patients were excluded if:
(1) they had dementia, mental retardation and ﬁbromyalgia
syndrome, (2) inability to write or read and (3) did not agree
to participate.
For those who fulﬁlled the inclusion criteria, the aim and
the process of the study along with conﬁdentiality of the gath-
ered information were described. If the patient agreed to con-
tinue and was orally consent to participate in the study, then
they were asked to complete 4 questionnaires including
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Anxiety and Depression Scale (HADS), Brief Illness Percep-
tion Scale (Brief-IPQ) and Rheumatoid Arthritis Pain Scale
(RAPS).
The study was approved by the research ethics board of
Isfahan University of Medical Sciences. An informed consent
was obtained from each participant.
2.2. Methods
Demographic variables such as age, gender and education were
obtained via self-report.
2.2.1. Depression (Predictor)
Depression, the primary predictor variable, was assessed using
the depression subscale of Hospital Anxiety and Depression
Scale (HADS). It was used to assess current levels of anxiety
and depression in non-psychiatric clinical populations [24].
The scale consists of 14 items (7 each for depression and anx-
iety). Each item is rated on a 4-point Likert-type scale ranging
from 0 (not at all) to 3 (very often). The possible scores for
each subscale ranges from 0 to 21, with higher scores indicat-
ing higher levels of symptomatology. Scores of 11 or above on
either subscale are considered to be a signiﬁcant ‘case’ of psy-
chological morbidity, while scores of 8–10 represent ‘border-
line’ and 0–7 ‘normal’ [25]. In general the Iranian version of
the HADS can be considered reliable and valid. Cronbach’s al-
pha coefﬁcient (to test reliability) has been found to be 0.86 for
the HADS depression (HADS-D) sub-scale and 0.78 for the
HADS anxiety sub-scale [25]. In the present study, Cronbach’s
alpha coefﬁcient for the HADS depression sub-scale was 0.84.
2.2.2. Illness perception (Mediator)
The Brief Illness Perception Questionnaire (Brief-IPQ) was
used to assess participant’s cognitive and emotional percep-
tions of RA. The Brief-IPQ is an eight self-report scale de-
signed to rapidly assess perceived consequences, time-line,
identity, treatment control, personal control, concern, emo-
tional representation, and coherence of one’s illness.
The consequence component reﬂects the individual’s beliefs
about the illness severity and likely the impact on physical,
psychological and social functioning. The time-line component
indicates their perceptions of the likely duration of their health
problems and these have been categorized as acute/short-last-
ing, chronic, or cyclical/episodic. The identity component is
concerned with patients’ ideas about the label, the nature of
their condition and the links between these. The treatment–
control indicates the extent to which the patient believes their
condition is amenable to cure or control. The other items in
the scale were personal control (how much control the patient
has over his or her disease), concern (how concerned the pa-
tient is about his or her disease), emotional response (how much
disease affects the patient emotionally) and coherence (how
well the patient feels he/she understands their disease).
All of the dimensions in the questionnaire are rated using 0
(no effect at all) to 10 (severely affects my life). Items are
scored such that higher responses on items 1, 2, 5, 6, and 8 rep-
resent more negative illness perceptions. Items 3, 4, and 7 are
scored such that higher responses indicate more positive illness
perceptions [26]. The items on the Brief IPQ have demon-
strated adequate test–retest reliability and predictive validityin samples of adults with various illnesses [26]. The Iranian
version of this questionnaire which was used in this study
has satisfactory psychometric properties [27].
2.2.3. Pain (Outcome)
The Rheumatoid Arthritis Pain Scale (RAPS) is a self-report
questionnaire. The RAPS was designed to measure pain in
RA patients. The content of RAPS is 24 items that measure
descriptions of pain. These items constitute the RAPS scale.
The items of RAPS include 4 subscales: physiologic compo-
nent (5 items), sensory-discriminative component (8 items),
affective component (4 items), and cognitive component (6
items). Items are scored on a 7-point Likert-type scale from
0 (always) to 6 (never). The scoring in RAPS questionnaire
is inverse type. Scores can range from 0 to 144: the higher
the score of the patient the lower the degree of pain and vice
versa. There is also 1 numerical rating scale of pain severity
perception. The Numerical Rating Scale has a 0–10 point scale
anchored by 0 (no pain) to 10 (extreme pain). After translating
the English version of RAPS into the Persian language and its
back translation to original language, this revised version was
compared with the original version and discrepancies were re-
solved. The ﬁnal version was administered to 20 patients and 3
items that were ambiguous were modiﬁed. The Cronbach’s al-
pha for the total RAPS was 0.91. Subscale alpha coefﬁcients
ranged from 0.64–0.86 [28]. In this sample, Cronbach’s alpha
coefﬁcient for the total RAPS was 0.83.
Statistical analysis: Data were analyzed with SPSS Version
16.0 for Windows. The results of Kolmogorov–Smirnov tests
did not reject normality in the populations. As a result, no
parametric tests were used throughout the analysis. As testing
of mediational models is warranted if there are signiﬁcant rela-
tions among the primary variables of interest, bivariate corre-
lations were calculated ﬁrst. In accordance with Baron and
Kenny [29], a series of regression analyses were used to exam-
ine the hypothesis that illness perceptions mediate the relation-
ship between depression (independent variable) and pain
(outcome variable). The ﬁrst set of regressions examined the
relationship between depression symptoms and illness percep-
tions. The second set of regressions examined the relationship
between depression symptoms and pain. Finally, the third set
of regressions examined the relationship between depression
and pain symptoms with illness perceptions included in the
model. Gender, age and pain severity were included as covar-
iates in the regression models. In accordance with guidelines
for testing meditational models, post-hoc probing (Sobel test)
was used to assess the signiﬁcance of each [30].3. Results
Descriptive data for pain, illness perception and depression
measures are presented in Table 1. Of the 100 participants,
66% endorsed clinically signiﬁcant level of depression (score
P11). The mean depression score (HADS) (12.94 ± 5.39)
indicates severe depressive symptoms. The mean score on the
measure of perceived pain symptoms was 41.97 ± 23.45;
(range = 4–91.93). Gender and education showed no signiﬁ-
cant effect on the presented results.
Higher levels of depression symptoms were associated with
more perceived pain as measured by RAPS (r= 0.57,
p< 0.001). Six of the eight individual illness perception
Table 2 Correlations between illness perception components
with Hospital Anxiety and Depression Scale Depression
subscale (HADS-D) and pain in rheumatoid arthritis patients.
Illness perception components RA patients (N= 100)
HADS-D Pain
Consequences 0.51** 0.54**
Timeline 0.44** 0.41**
Personal control 0.38** 0.34**
Treatment control 0.16 0.11
Identity 0.35** 0.34**
Concern 0.26** 0.25*
Comprehensibility 0.1 0.18
Emotional response 0.32** 0.39**
RA: rheumatoid arthritis; HADS-D: Hospital Anxiety and
Depression Scale Depression subscale.
* Signiﬁcant at p< 0.05.
** Signiﬁcant at p< 0.01.
Table 1 Illness perception, pain and depression scores in rheumatoid arthritis patients.
Variables Rheumatoid arthritis patients (N= 100)
Mean(±SD) Range
Illness perception questionnaire
Consequences
How much does pain aﬀect your life?
4.83 (±2.23) 1–10
Timeline
How long do you think your pain will continue?
5.05 (±1.94) 2–10
Personal control
How much control do you have over your pain?
5.08 (±1.67) 1–9
Treatment control
How much do you think your treatment can help your pain?
6.62 (±1.99) 0–10
Identity
How much do you experience symptoms from your pain?
5.17 (±2.03) 1–9
Concern
How concerned are you about your pain?
5.22 (±2.1) 1–10
Comprehensibility
How well do you feel you understand your pain?
5.1 (±2.52) 0–10
Emotional response
How much does your pain aﬀect you emotionally?
5.33 (±2.23) 1–10
Pain
Total Rheumatoid Arthritis Pain Scale (RAPS) 41.97 (±23.45) 4–91.3
Physiologic component 10.1 (±6.47) 1–27
Aﬀective component 9.07 (±5.79) 0–29
Sensory-discriminative component 12.46 (±9.28) 1–51
Cognitive component 10.35 (±6.69) 1–31.49
Pain severity 6.49 (±2.57) 1–10
HADS-D 12.94 (±5.39) 0–21
HADS-D: Hospital Anxiety and Depression Scale Depression subscale.
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depression and pain symptoms (p< 0.05): (1) consequences,
(2) timeline, (3) personal control, (4) identity, (5) Concern
and (6) Emotional representations (Table 2). Because correla-
tions were signiﬁcant for these six illness perceptions (potential
mediators), a set of three regression analyses was conducted
for each illness perception.
The ﬁrst set of regression analyses included depression
and covariates as independent variables and each of thesix illness perceptions as the dependent variable. The regres-
sion models were signiﬁcant for ﬁve of the six illness percep-
tions, with greater depression predicting more negative
illness perceptions. Greater depression symptoms were linked
with perceptions that pain has a greater effect on RA’s life
and emotion. In addition, increased depression symptoms
were related to a longer perceived duration of pain, more
symptoms of pain and less perceived control over pain
symptoms.
The second set of analyses was one regression analysis with
depression at baseline and covariates predicting perceived pain
symptoms. The regression model was signiﬁcant F (4,
93) = 25.62, p= 0.00, with increased depression (b= 0.40,
p= 0.00), and covariate (increased pain severity, b= 0.32,
p= 0.001) associated with more pain symptoms.
The third set of regression models included both depression
and the ﬁve aforementioned illness perceptions, along with the
covariates, as predictors of perceived pain symptoms. All ﬁve
proposed mediators were signiﬁcantly related to perceived pain
symptoms (Table 3). In the ﬁrst model, greater pain symptoms
were predicted by RA’s perceptions that pain greatly affected
their life (p= 0.001), increased pain severity (p= 0.001),
and increased depression symptoms (p= 0.01), F (16,
92) = 16.15, p= 0.00, adjusted R2 = 0.43. In the second mod-
el, greater pain was predicted by longer perceived duration of
pain (p< 0.05), increased pain severity (p= 0.001), and in-
creased depression symptoms (p= 0.001), F (5, 92) = 13.73,
p= 0.00, adjusted R2 = 0.39. In the third model, increased
depression symptoms (p= 0.00), increased pain severity
Table 3 Final regression models predicting pain in rheumatoid arthritis patients.
Variables of the 5 models Rheumatoid arthritis patients (N= 100)
Standardized b T Adjusted R2
Model 1
Consequences
How much does pain aﬀect your life?
0.30 3.36*** 0.43
Depression 0.27 2.83**
Pain severity 0.29 3.35***
Gender 0.005 0.06
Age 0.008 0.1
Model 2
Timeline
How long do you think your pain will continue?
0.177 2.02* 0.39
Depression 0.33 3.42***
Pain severity 0.31 3.51***
Gender 0.04 0.49
Age 0.006 0.07
Model 3
Personal control
How much control do you have over your pain?
0.137 1.58* 0.38
Depression 0.36 3.74***
Pain severity 0.31 3.45***
Gender 0.04 0.59
Age 0.011 0.136
Model 4
Identity
How much do you experience symptoms from your pain?
0.143 1.69* 0.38
Depression 0.35 3.74***
Pain severity 0.32 3.54***
Gender 0.05 0.63
Age 0.01 0.22
Model 5
Emotional response
How much does your pain aﬀect you emotionally?
0.21 2.54** 0.41
Depression 0.34 3.81***
Pain severity 0.31 3.46***
Gender 0.01 0.195
Age 0.003 0.03
* Signiﬁcant at p< 0.05.
** Signiﬁcant at p< 0.01.
*** Signiﬁcant at p< 0.001.
Psychological factors in rheumatoid arthritis 61(p= 0.001) and lower perceived control over pain (p< 0.05),
predicted greater pain, F (5, 92) = 13.03, p= 0.00, R2 = 0.38.
In the fourth model, increased experience symptoms of pain
(p< 0.05), increased pain severity (p= 0.001) and increased
depression symptoms (p= 0.001) predicted greater pain, F
(5, 92) = 13.32, p= 0.00, adjusted R2 = .389. In the ﬁfth
model, increased emotional impact of pain (p= 0.01),
increased depression symptoms (p= 0.00) and increased pain
severity (p= 0.001) predicted greater pain, F (5, 92) = 17.94,
p= 0.00, R2 = 0.41.
When both illness perceptions and depression were included
in the model, the effect of depression symptoms on pain (as
indicated by b) was reduced in all ﬁve models. Post-hoc exam-
ination of these models using the Sobel test indicated three sig-
niﬁcant mediators: (1) ‘‘consequences’’ z= 1.39, p< 0.05; (2)
‘‘personal control’’ z= 1.47, p< 0.05; (3) ‘‘emotional re-
sponse’’ z= 1.51, p< 0.05. The fourth and ﬁfth illness percep-
tions (‘‘timeline’’ z= 1.25, p= 0.09; and ‘‘identity’’ z= 1.32,
p= 0.08) approached signiﬁcance as a mediator.4. Discussion
According to HADS-D questionnaire, threshold a score of 11
and over, more than 50% of RA patients would be regarded as
probable cases of depression disorder. These rates of depres-
sion’s symptoms are similar to rates obtained in previous stud-
ies of patients with RA [31]. In other studies conducted on
patients with RA, prevalence of depression has been reported
to be from 14% to 46% [15,32,33].
The chronicity of illness as well as the ever-present possibility
of patient’s suffering pain is the possible cause of psychiatric dis-
orders in RA [9]. Physical disability that develop in the course of
the disease leads to dissatisfaction in the family life andwork sta-
tus of patients, who become socially isolated due to inadequacy
to fulﬁll their goals [34,35].Moreover, patients become hospital-
bound due to their deﬁcient functional outcomes [32] and unable
to sustain themselves [35], and economic strains and lack of so-
cial support [36,37] leads to depression.
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sion symptoms were related to more pain, more functional
impairment, more serious perceived consequences and less
control over the illness [38–41]. This is important because these
factors may contribute to poor compliance with RA
medication. Thus depression screening for individuals report-
ing numerous pain symptoms despite reported adherence to
the prescribed medical regimen could help determine whether
or not depression symptoms may be contributing to pain
symptoms.
As hypothesized, the relationship between depression
symptoms and pain was partially mediated by illness percep-
tions. Speciﬁcally, higher levels of depression were associated
with the feeling that one’s pain negatively affected one’s life
and emotions, and difﬁcult to control. These negative illness
perceptions, in turn, were related to greater pain symptoms.
This study highlights the importance of the patient’s beliefs
and emotional responses to their symptoms and illness as
key factors inﬂuencing satisfaction with the consultation and
the further use of health care systems.
The ﬁndings about the role of illness perception as a medi-
ator between the pain and depression in this study offer sup-
port to the existing body of research. In a study by Pilowsky
[42], a depressed group of RA sufferers was found to perceive
their illness as being more serious and feel hopeless about a
cure compared with the non-depressed RA group, even when
the actual severity of arthritis was adjusted for.
One of the ﬁrst longitudinal studies to document the impor-
tance of illness perception in RA patients was a study involv-
ing a sample of 75 younger female patients [43]. The authors
found that depression was consistently predicted by pain, pas-
sive coping and beliefs about the consequences of RA. Similar
ﬁndings were reported by Zyrianova et al. [44] in their study of
the complex relationship of illness perception with physical
and psychological factors in RA using a structural model.
Zyrianova et al. [44] concluded that illness perception was to
be a mediator in the relationship between physical disability
and depression and anxiety.
Given the high rates of RA and co-morbid depression, it
is important to explore interventions that aimed to improve
outcomes. The ﬁndings of this study suggest that illness per-
ceptions could be tested in a pilot psychological intervention
as a means to potentially improve pain symptoms in RA pa-
tients. Cognitive behavioral therapy has been shown to effec-
tively reduce symptoms of pain in RA patients [45–47].
Illness perceptions are well identiﬁed as a target for treat-
ment [47–51]. No study was found on illness perception fo-
cused therapy on RA patients in the related literature. The
data of this study suggest that addressing illness perceptions
in treatment may result in pain-related changes. For exam-
ple, if illness perceptions are incorporated as part of the cog-
nition behavior ‘‘framework’’ treatment, it may address co-
morbid depression more precisely, thus affecting pain-related
outcomes such as symptoms. In particular, the results sug-
gest that addressing patient’s perceived control of rheuma-
toid arthritis and perceived affect of pain on their life and
emotions may have the potential to lead to decrease in pain
symptoms. These hypotheses are supported by study in other
chronic illness populations. For example, in a sample of
adults with back pain, treatment of illness perceptions
accounted for 14.4% of the variance in improved patient-
relevant activities [52].The results of this study should be interpreted within the
context of several limitations. First, this study was cross-sec-
tional and only prospective analyses will give an exhaustive
picture of the causal relationships between variables. For
example, it is possible that illness perceptions may lead to in-
creased symptoms of depression. Future studies should exam-
ine this relationship. Second, because we were interested in
investigating speciﬁc mediators that clinicians could target in
practice, we did not simultaneously examine all variables as
mediators. As a result, it is not possible to draw conclusions
concerning the combined effect of all three mediators. Third,
in this study the self-report questionnaire was used to assess
the pain. However, as an alternative to self report question-
naire, it is reasonable to use scales surveying rheumatologist’s
opinions such as the disease activity scale. Finally, our samples
were representatives of the RA patients who live in Isfahan
City and the results can be generalized only to similar cultural
setting.
Despite these limitations, this study provides additional
information regarding the relationship between depression
and pain in adult with RA patients. Targeting illness percep-
tions should be considered when working clinically to im-
prove outcomes in adults with RA and co-morbid
depression. Future studies should empirically test whether
cognitive behavior interventions that target negative illness
perceptions such as perceived control of pain are effective
for patients in sustaining both short and long term reduction
of pain symptoms.Conﬂict of interest
The authors declare no conﬂicts of interest.References
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